Twelve cities are racing to be named the European Capital of Innovation 2026 as part of the iCapital Awards. These cities are now one step closer to securing recognition and significant financial support for their efforts in driving inclusive, citizen-focused innovation.
Zachary Senwo, Fulbright Scholar & Professor of Soil Microbial Biochemistry, Environmental Science & Toxicology at Alabama A&M University, explores nitrogen cycling in sustaining soil health and agricultural systems.
The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".
Rachel Cheng, Communications Manager & Gisèle Yasmeen, Executive Director from Food Secure Canada, argue that post-COVID, a zero hunger Canada is within reach.
Noa Khamallah, former Executive at Voi and Lime, argues that not only are e-scooters the perfect fit for the cities of the future but they can also help speed up the UK's emergence from the pandemic.
Rick Goud, Chief Information Officer at Zivver, discusses the importance of becoming a digital enabler through implementing accessible and user-friendly security solutions.
Hannah Paterson, Principal Consultant at Step5, points out how to spot if someone is struggling with their mental health from a distance and how to encourage a culture of wellbeing to prevent issues from developing in the first place.
Jacob Bor, Assistant Professor in Global Health and Epidemiology at Boston University School of Public Health, says COVID shed light on what he describes as "decades of neglect".
Faisal Abbasi, Managing Director Western Europe and MEMA, Amelia, explores how the government can make the most of its Help to Grow scheme to boost entrepreneurship and create the next generation of technology leaders.
In a significant breakthrough for life science, Israeli scientists have succeeded in growing mice embryos in artificial wombs - completely outside the body.
The NHS released new information explaining that there would be a vaccine shortage in the UK from 29 March, meaning under-50s will wait longer for their first jab as second doses are given to the most vulnerable cohorts.
